Private equity firms who hold 39% of Lyra Therapeutics, Inc. (NASDAQ:LYRA) gained 6.8%, institutions profited as well [Yahoo! Finance]
Lyra Therapeutics, Inc. (LYRA)
Company Research
Source: Yahoo! Finance
51% of the business is held by the top 5 shareholders Institutions own 32% of Lyra Therapeutics To get a sense of who is truly in control of Lyra Therapeutics, Inc. ( NASDAQ:LYRA ), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are private equity firms with 39% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company. While private equity firms were the group that reaped the most benefits after last week's 6.8% price gain, institutions also received a 32% cut. Let's take a closer look to see what the different types of shareholders can tell us about Lyra Therapeutics. See our latest analysis for Lyra Therapeutics What Does The Institutional Ownership Tell Us About Lyra Therapeutics? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that a
Show less
Read more
Impact Snapshot
Event Time:
LYRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LYRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LYRA alerts
High impacting Lyra Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LYRA
News
- Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock? [Yahoo! Finance]Yahoo! Finance
- Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why [Yahoo! Finance]Yahoo! Finance
- Lyra Therapeutics, Inc. (NASDAQ: LYRA) had its price target lowered by analysts at Bank of America Co. from $12.00 to $11.00. They now have a "buy" rating on the stock.MarketBeat
LYRA
Earnings
- 8/8/23 - Beat
LYRA
Sec Filings
- 4/19/24 - Form PRE
- 4/19/24 - Form 8-K
- 4/2/24 - Form EFFECT
- LYRA's page on the SEC website